Lineage, Inc. Common Stock (LINE)vsUniversal Health Realty Income Trust (UHT)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
UHT
Universal Health Realty Income Trust
$40.40
-1.75%
REAL ESTATE · Cap: $567.48M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 5210% more annual revenue ($5.37B vs $101.15M). UHT leads profitability with a 19.1% profit margin vs -3.1%. UHT earns a higher WallStSmart Score of 65/100 (C+).
LINE
Avoid35
out of 100
Grade: F
UHT
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+45.9%
Fair Value
$79.20
Current Price
$40.40
$38.80 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 37.9%
Growing faster than its price suggests
Earnings expanding 33.4% YoY
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Moderate valuation
0.7% revenue growth
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : UHT
The strongest argument for UHT centers on Operating Margin, PEG Ratio, EPS Growth. Profitability is solid with margins at 19.1% and operating margin at 37.9%. PEG of 0.63 suggests the stock is reasonably priced for its growth.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : UHT
The primary concerns for UHT are P/E Ratio, Revenue Growth, Market Cap. Debt-to-equity of 2.75 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while UHT is a value play — different risk/reward profiles.
LINE carries more volatility with a beta of 0.88 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
UHT scores higher overall (65/100 vs 35/100), backed by strong 19.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Universal Health Realty Income Trust
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including intensive care hospitals, rehabilitation hospitals, subacute care facilities, medical / office buildings, emergency departments independent and child care centers.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?